Last reviewed 2026-06-10 · How we verify

sour stomach — Treatment Landscape & Competitive Intelligence

sour stomach (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating sour stomach, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Bayer HealthCare LLC. · 1 drug in sour stomach
2. Target Corporation · 1 drug in sour stomach

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in sour stomach:

• sour stomach treatment updates — RSS
• sour stomach treatment updates — Atom
• sour stomach treatment updates — JSON

Cite this brief

Drug Landscape (2026). sour stomach — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/sour-stomach. Accessed 2026-06-10.

Related

• sour stomach full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing